R Brinks1, R Fischer-Betz2, O Sander2, J G Richter2, G Chehab2, M Schneider2. 1. Policlinic of Rheumatology, Heinrich-Heine-University, Düsseldorf, Germany Institute for Biometry and Epidemiology at the German Diabetes Center, Düsseldorf, Germany ralph.brinks@ddz.uni-duesseldorf.de. 2. Policlinic of Rheumatology, Heinrich-Heine-University, Düsseldorf, Germany.
Abstract
OBJECTIVE: The objective of this report is to estimate the prevalence and future number of cases of systemic lupus erythematosus (SLE) in Germany. METHODS: Data from a representative sample of all insurants from the statutory health insurance in Germany comprising more than 2.3 million individuals have been screened for SLE diagnoses. The gender- and age-specific prevalence of SLE is calculated. The case definition is based on at least one recorded diagnosis of SLE during 2002. The stratum-specific prevalence is applied to the current and the future population of Germany in order to estimate and predict the number of people with SLE until 2030. RESULTS: The overall prevalence of diagnosed SLE in 2002 was 15.4 (95% CI: 13.1-17.9) and 55.4 (51.4, 59.8) per 100,000 in the male and female German population. This corresponds to an estimated 30,000 and 31,000 people with diagnosed SLE in 2002 and 2010, respectively. This number will slightly increase until 2020 and decrease thereafter. CONCLUSIONS: Compared with health insurance data from France, the prevalence in our data is similar. Under the assumption that the gender- and age-specific prevalence of SLE in Germany will not change considerably, the number of cases in the next two decades will change only slightly.
OBJECTIVE: The objective of this report is to estimate the prevalence and future number of cases of systemic lupus erythematosus (SLE) in Germany. METHODS: Data from a representative sample of all insurants from the statutory health insurance in Germany comprising more than 2.3 million individuals have been screened for SLE diagnoses. The gender- and age-specific prevalence of SLE is calculated. The case definition is based on at least one recorded diagnosis of SLE during 2002. The stratum-specific prevalence is applied to the current and the future population of Germany in order to estimate and predict the number of people with SLE until 2030. RESULTS: The overall prevalence of diagnosed SLE in 2002 was 15.4 (95% CI: 13.1-17.9) and 55.4 (51.4, 59.8) per 100,000 in the male and female German population. This corresponds to an estimated 30,000 and 31,000 people with diagnosed SLE in 2002 and 2010, respectively. This number will slightly increase until 2020 and decrease thereafter. CONCLUSIONS: Compared with health insurance data from France, the prevalence in our data is similar. Under the assumption that the gender- and age-specific prevalence of SLE in Germany will not change considerably, the number of cases in the next two decades will change only slightly.
Authors: Albert Rosenberger; Melanie Sohns; Stefanie Friedrichs; Rayjean J Hung; Gord Fehringer; John McLaughlin; Christopher I Amos; Paul Brennan; Angela Risch; Irene Brüske; Neil E Caporaso; Maria Teresa Landi; David C Christiani; Yongyue Wei; Heike Bickeböller Journal: PLoS One Date: 2017-03-08 Impact factor: 3.240
Authors: Raúl Cortés Verdú; José M Pego-Reigosa; Daniel Seoane-Mato; Mercedes Morcillo Valle; Deseada Palma Sánchez; María J Moreno Martínez; Marta Mayor González; Joana Atxotegi Sáenz de Buruaga; Irati Urionagüena Onaindia; Boris A Blanco Cáceres; Lucía Silva-Fernández; Francisca Sivera; Francisco J Blanco; Carlos Sánchez-Piedra; Federico Díaz-González; Sagrario Bustabad Journal: Rheumatology (Oxford) Date: 2020-09-01 Impact factor: 7.580
Authors: Andreas Schwarting; Heiko Friedel; Elena Garal-Pantaler; Marc Pignot; Xia Wang; Henk Nab; Barnabas Desta; Edward R Hammond Journal: Rheumatol Ther Date: 2021-02-05
Authors: Carsten Oliver Schmidt; Klaus-Peter Günther; Jens Goronzy; Katinka Albrecht; Jean-François Chenot; Johanna Callhoff; Adrian Richter; Richard Kasch; Wolfgang Ahrens; Heiko Becher; Klaus Berger; Hermann Brenner; Beate Fischer; Claus-Werner Franzke; Wolfgang Hoffmann; Bernd Holleczek; Lina Jaeschke; Carsten Jenning; Karl-Heinz Jöckel; Rudolf Kaaks; Thomas Keil; Alexander Kluttig; Gérard Krause; Oliver Kuß; Michael Leitzmann; Wolfgang Lieb; Jakob Linseisen; Markus Löffler; Claudia Meinke-Franze; Christa Meisinger; Karin B Michels; Rafael Mikolajczyk; Nadia Obi; Annette Peters; Tobias Pischon; Tamara Schikowski; Sabine Schipf; Christof Specker; Henry Völzke; Kerstin Wirkner; Angela Zink; Oliver Sander Journal: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Date: 2020-04 Impact factor: 1.513